Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUC3-053 in Dry Eye Syndrome
NCT06388070Phase 3Completed
- Sponsor
- Huons
- Start
- May 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HUC3-053 in dry eye syndrome (DED), sponsored by Huons. Started May 2024; status: completed.
02
Drugs
HUC3-053
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06388070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06388070.